Skip to main content

Vitamin D, Autoimmune Diseases, and Systemic Lupus Erythematosus

  • Chapter
  • First Online:
Connective Tissue Disease

Abstract

Vitamin D is a steroid hormone that influences glucocorticoids and gonadal hormones, interfering with the immune system and estrogen-modulated cells. Therefore vitamin D deficiency is thought as a risk factor for several chronic inflammatory and autoimmune conditions.

A possible synergism between 1,25(OH)D3 and glucocorticoids could represent a new approach for the management of chronic autoimmune diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cutolo M, Pizzorni C, Sulli A (2011) Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun Rev 11:84–87

    Article  CAS  PubMed  Google Scholar 

  2. Cutolo M, Plebani M, Shoenfeld Y et al (2011) Vitamin D endocrine system and the immune response in rheumatic diseases. Vitam Horm 86:327–351

    Article  CAS  PubMed  Google Scholar 

  3. Ruiz-Irastorza G, Egurbide MV, Olivares N et al (2008) Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology 47:920–923

    Article  CAS  PubMed  Google Scholar 

  4. Cusack C, Danby C, Fallon JC et al (2008) Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus. Photodermatol Photoimmunol Photomed 24:260–267

    Article  PubMed  Google Scholar 

  5. Agmon-Levin N, Theodor E, Segal RM et al (2013) Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol 45:256–266

    Article  CAS  PubMed  Google Scholar 

  6. Adorini L, Penna G (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4:404–412

    Article  CAS  PubMed  Google Scholar 

  7. Pludowski P, Holick MF, Pilz S et al (2013) Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 12:976–989

    Article  CAS  PubMed  Google Scholar 

  8. Holick MF (2003) Vitamin D: a millennium perspective. J Cell Biochem 88:296–307

    Article  CAS  PubMed  Google Scholar 

  9. Cutolo M, Otsa K, Laas K et al (2006) Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 24:702–704

    CAS  PubMed  Google Scholar 

  10. Dall’Ara F, Andreoli L, Piva N et al (2015) Winter lupus flares are associated with low vitamin D levels in a retrospective longitudinal study of Italian adult patients. Clin Exp Rheumatol 33:153–158

    PubMed  Google Scholar 

  11. Cutolo M (2009) Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis 68(3):446–447

    Article  CAS  PubMed  Google Scholar 

  12. Cutolo M, Otsa K, Uprus M et al (2007) Vitamin D in rheumatoid arthritis. Autoimmun Rev 7:59–64

    Article  CAS  PubMed  Google Scholar 

  13. Schoindre Y, Jallouli M, Tanguy ML et al (2014) Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up. Lupus Sci Med 1(1), e000027

    Article  PubMed  PubMed Central  Google Scholar 

  14. Wang J, Nuite M, McAlindon TE (2010) Association of estrogen and aromatase gene polymorphisms with systemic lupus erythematosus. Lupus 19:734–744

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Cutolo M (2010) Hormone therapy in rheumatic diseases. Curr Opin Rheumatol 22:257–263

    Article  CAS  PubMed  Google Scholar 

  16. Souberbielle JC, Body JJ, Lappe JM et al (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9:709–715

    Article  CAS  PubMed  Google Scholar 

  17. Andreoli L, Dall’Ara F, Piantoni S et al (2015) A 24 months, prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus. Lupus 24:499–506

    Google Scholar 

  18. Olliver M, Spelmink L, Hiew J et al (2013) Immunomodulatory effects of vitamin D on innate and adaptive immune responses to Streptococcus pneumoniae. J Infect Dis 208:1474–1481

    Article  CAS  PubMed  Google Scholar 

  19. Cantorna MT, Mahon BD (2004) Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 229:1136–1142

    CAS  Google Scholar 

  20. Gatenby P, Lucas R, Swaminathan A (2013) Vitamin D deficiency and risk for rheumatic diseases: an update. Curr Opin Rheumatol 25:184–191

    Article  CAS  PubMed  Google Scholar 

  21. Tiosano D, Wildbaum G, Gepstein V et al (2013) The role of vitamin D receptor in innate and adaptive immunity: a study in hereditary vitamin D-resistant rickets patients. J Clin Endocrinol Metab 98:1685–1693

    Article  CAS  PubMed  Google Scholar 

  22. Terrier B, Derian N, Schoindre Y et al (2012) Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther 14:R221

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Borgogni E, Sarchielli E, Sottili M et al (2008) Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. Endocrinology 149:3626–3634

    Article  CAS  PubMed  Google Scholar 

  24. Rausch-Fan X, Leutmezer F, Willheim M et al (2002) Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3. Int Arch Allergy Immunol 128:33–41

    Article  CAS  PubMed  Google Scholar 

  25. Colin EM et al (2010) 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 62:132–142

    Article  CAS  PubMed  Google Scholar 

  26. van Hamburg JP, Asmawidjaja PS, Davelaar N et al (2012) TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation. Ann Rheum Dis 71:606–612

    Article  PubMed  Google Scholar 

  27. Sasano H, Miki Y, Nagasaki S, Suzuki T (2009) In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology. Pathol Int 59:777–789

    Article  CAS  PubMed  Google Scholar 

  28. Haque UJ, Bartlett SJ (2010) Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clin Exp Rheumatol 28:745–747

    CAS  PubMed  Google Scholar 

  29. Gopinath K, Danda D (2011) Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial. Int J Rheum Dis 14:332–339

    Article  PubMed  Google Scholar 

  30. Jirapongsananuruk O, Melamed I, Leung DY (2000) Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses. J Allergy Clin Immunol 106:981–985

    Article  CAS  PubMed  Google Scholar 

  31. Hidalgo AA, Deeb KK, Pike JW et al (2011) Dexamethasone enhances 1,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcription. J Biol Chem 286:36228–36237

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7:684–700

    Article  CAS  PubMed  Google Scholar 

  33. Mangelsdorf DJ, Thummel C, Beato M et al (1995) The nuclear receptor superfamily: the second decade. Cell 83:835–839

    Article  CAS  PubMed  Google Scholar 

  34. Kallay E, Pietschmann P, Toyokuni S et al (2001) Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 22:1429–1435

    Article  CAS  PubMed  Google Scholar 

  35. Yu WD, McElwain MC, Madzelewski RA et al (1998) Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone. J Natl Cancer Inst 90:134–141

    Article  CAS  PubMed  Google Scholar 

  36. Zhang Y, Leung DY, Goleva E (2013) Vitamin D enhances glucocorticoid action in human monocytes: involvement of granulocyte-macrophage colony-stimulating factor and mediator complex subunit 14. J Biol Chem 288:14544–14553

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Searing DA, Zhang Y, Murphy JR et al (2010) Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol 125:995–1000

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Menter A, Gold S, Bukualo M et al (2013) Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial. J Drugs Dermatol 12:92–98

    CAS  PubMed  Google Scholar 

  39. Kragballe K, Austad J, Barnes L et al (2008) A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris. Br J Dermatol 154:1155–1160

    Article  Google Scholar 

  40. Azali P, Barbasso Helmers S, Kockum I et al (2013) Low serum levels of vitamin D in idiopathic inflammatory myopathies. Ann Rheum Dis 72:512–516

    Article  CAS  PubMed  Google Scholar 

  41. Prietl B, Pilz S, Wolf M et al (2010) Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr Med Assoc J 12:136–139

    PubMed  Google Scholar 

  42. Ritterhouse LL, Crowe SR, Niewold TB et al (2011) Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 70:1569–1574

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Mok CC, Birmingham DJ, Ho LY et al (2012) Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus 21:36–42

    Article  CAS  PubMed  Google Scholar 

  44. Li W, Zhang R, Zhang K et al (2012) Reduced vitamin D levels are associated with autoimmune response in tuberculosis patients. Ann Rheum Dis 71:790–794

    Article  PubMed  Google Scholar 

  45. Cutolo M, Sulli A, Straub RH (2013) Estrogen’s effects in chronic autoimmune/inflammatory diseases and progression to cancer. Expert Rev Clin Immunol 10(1):31–39

    Article  PubMed  Google Scholar 

  46. Krishnan AV, Swami S, Peng L et al (2010) Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 5:32–34

    Article  Google Scholar 

  47. Krishnan AV, Swami S, Feldman D (2012) The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer. Steroids 77:1107–1112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Villaggio B, Soldano S, Cutolo M (2012) Vitamin D modulates aromatase expression in human macrophages and downregulates proinflammatory cytokine production via ERK/MAPK signaling. Ann Rheum Dis 71(supl1):A75

    Article  Google Scholar 

  49. Villaggio B, Soldano S, Cutolo M (2012) 1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. Clin Exp Rheumatol 30:934–938

    PubMed  Google Scholar 

  50. Cutolo M (2012) The challenges of using vitamin D in cancer prevention and prognosis. Isr Med Assoc J 14:637–639

    PubMed  Google Scholar 

  51. Cutolo M, Sulli A, Straub RH (2012) Estrogen metabolism and autoimmunity. Autoimmun Rev 11:A460–A464

    Article  CAS  PubMed  Google Scholar 

  52. Capellino S, Montagna P, Villaggio B et al (2008) Hydroxylated estrogen metabolites influence the proliferation of cultured human monocytes: possible role in synovial tissue hyperplasia. Clin Exp Rheumatol 26:903–909

    CAS  PubMed  Google Scholar 

  53. Bosland MC, Mahmoud AM (2011) Hormones and prostate carcinogenesis: androgens and estrogens. J Carcinog 10:33–37

    Article  PubMed  PubMed Central  Google Scholar 

  54. Correale J, Ysrraelit MC, Gaitán MI (2009) Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 132:1146–1160

    Article  PubMed  Google Scholar 

  55. Mok CC (2013) Vitamin D and systemic lupus erythematosus: an update. Expert Rev Clin Immunol 9:453–463

    Article  CAS  PubMed  Google Scholar 

  56. Rahman A, Isenberg DA (2008) Systemiclupuserythematosus. N Engl J Med 358:929–939

    Article  CAS  PubMed  Google Scholar 

  57. Yap K, Morand E (2015) Vitamin D and systemic lupus erythematosus: continued evolution. Int J Rheum Dis 18(2):242–249

    Google Scholar 

  58. Birmingham DJ, Hebert LA, Song H et al (2012) Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 21(8):855–864

    Article  CAS  PubMed  Google Scholar 

  59. Piantoni S, Andreoli L, Zanola A et al (2015) Phenotype modifications of T-cells and their shift towards a Th2 response in patients with systemic lupus erythematos supplemented with monthly different regimens of vitamin D. Lupus 24:490–498

    Google Scholar 

  60. Sahebari M, Nabavi N, Salehi M (2014) Correlation between serum 25(OH)D values and lupus disease activity: an original article and a systematic review with meta-analysis focusing on serum VitD confounders. Lupus 23:1164–1177

    Article  CAS  PubMed  Google Scholar 

  61. Stagi S, Cavalli L, Bertini F et al (2014) Vitamin D levels in children, adolescents, and young adults with juvenile-onset systemic lupus erythematosus: a cross-sectional study. Lupus 23(10):1059–1065

    Article  CAS  PubMed  Google Scholar 

  62. Cutolo M (2013) Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis. Ann Rheum Dis 72:473–475

    Article  CAS  PubMed  Google Scholar 

  63. Reynolds J, Ray D, Alexander MY et al (2015) Role of vitamin D in endothelial function and endothelial repair in clinically stable systemic lupus erythematosus. Lancet 385(Suppl 1):S83

    Google Scholar 

  64. Kokic V, Martinovic Kaliterna D et al (2015) Relationship between vitamin D, IFN-γ, and E2 levels in systemic lupus erythematosus. Lupus. pii: 0961203315605367. [Epub ahead of print]

    Google Scholar 

Download references

Conflicts of Interest

The authors declare no conflicts of interest with the contents of the present manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maurizio Cutolo .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Paolino, S., Smith, V., Pizzorni, C., Seriolo, B., Sulli, A., Cutolo, M. (2016). Vitamin D, Autoimmune Diseases, and Systemic Lupus Erythematosus. In: Roccatello, D., Emmi, L. (eds) Connective Tissue Disease. Rare Diseases of the Immune System. Springer, Cham. https://doi.org/10.1007/978-3-319-24535-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-24535-5_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-24533-1

  • Online ISBN: 978-3-319-24535-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics